查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585659

生医光电市场：按应用、最终用途分类 - 2025-2030 年全球预测

Biophotonics Market by Application (Biosensors, Inside Imaging, Light Therapy), End-Use (Medical Diagnostics, Medical Therapeutics, Non-Medical Application) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年生医光电市值为579.1亿美元，预计到2024年将达到631.4亿美元，复合年增长率为9.12%，到2030年将达到1067.1亿美元。

生医光电是一个跨学科领域，它将基于光的技术应用于生物材料的研究。这包括开发和使用光子装置和技术，用于在分子和细胞层面分析、成像和操纵生物组织。对光电的需求源自于其提供非侵入性、高解析度、高精度诊断和治疗解决方案的能力，大大推进了医学研究、诊断和治疗。主要应用包括光学同调断层扫瞄、显微镜和光谱学等成像系统，它们在早期疾病检测、个人化医疗和微创治疗中发挥关键作用。主要的最终用途领域是医疗、製药、生物技术和环境监测，由于对先进诊断程序和治疗的需求不断增长，医疗成为主要驱动力。

主要市场统计
基准年[2023] 579.1亿美元
预测年份 [2024] 631.4亿美元
预测年份 [2030] 1067.1亿美元
复合年增长率（%） 9.12%

市场成长是由技术进步、政府研究经费增加以及对早期疾病检测技术的认识不断提高所推动的。慢性病的增加和世界人口的老化进一步增加了对创新诊断和治疗解决方案的需求。最近的全球健康危机凸显了对非接触式医疗保健解决方案的需求，在扩大远端医疗和远距离诊断的使用方面存在潜在机会。然而，昂贵的设备、复杂的监管要求以及缺乏熟练专业人员等挑战构成了重大障碍。此外，快速的技术进步需要不断的研发投资，这可能会对中小企业的商业资源造成压力。

生医光电的创新可以针对具有成本效益的可携式诊断工具，并与人工智慧集成，以增强资料分析和预测诊断。奈米级成像和微创光学生物感测器也应被视为潜在的成长领域。学术界和工业界的合作可以加速技术进步。市场格局充满活力且快速成长，其特点是密集的研发活动和不断发展的技术范式。公司可以透过投资新技术、促进跨学科合作以及根据医疗保健提供者和患者的特定需求量身定制解决方案来保持竞争力。

市场动态：揭示快速发展的生医光电市场的关键市场洞察

供需的动态交互作用正在改变生医光电市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 老年人口增加
    • 新型光声断层扫描（PAT）系统的开发
    • 生医光电应用于细胞/组织诊断
  • 市场限制因素
    • 不愿意采用新的治疗方法
  • 市场机会
    • 生医光电在非医疗领域的应用
    • 奈米科技的出现
  • 市场问题
    • 对生医光电技术缺乏认识

波特五力：驾驭生医光电市场的策略工具

波特的五力框架是了解生医光电市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解生医光电市场的外部影响

外部宏观环境因素在塑造生医光电市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解生医光电市场的竞争格局

对生医光电市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵生医光电市场供应商的绩效评估

FPNV定位矩阵是评估生医光电市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製生医光电市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对生医光电市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人口增加
      • 新型光声成像（PAT）系统的开发
      • 生医光电在细胞和组织诊断的应用
    • 抑制因素
      • 抵制引入新治疗方法
    • 机会
      • 生医光电在医疗领域以外的应用
      • 奈米科技的出现
    • 任务
      • 对生医光电技术缺乏认识
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章生医光电市场：依应用分类

  • 介绍
  • 生物感测器
  • 内部影像
  • 光疗
  • 显微镜检查
  • 透视成像
  • 光谱分子
  • 表面成像

第七章生医光电市场：依最终用途

  • 介绍
  • 医学诊断
  • 医疗
  • 非医疗用途
  • 测试和组件

第八章北美和南美生医光电市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太生医光电市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的生医光电市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Becton, Dickinson and Company
  • Carl Zeiss AG
  • Hamamatsu Photonics KK
  • Idex Corporation
  • ImpediMed Limited
  • Lumenis Be Ltd.
  • LUMICKS Technologies BV
  • Magritek
  • Olympus Corporation
  • Oxford Instruments Group
  • PerkinElmer Inc.
  • Photopharmics, Inc.
  • Thermo Fisher Scientific Inc.
  • THINKCYTE Inc.
  • VivoSight by Michelson Diagnostics Ltd.
Product Code: MRR-437D45957BF6

The Biophotonics Market was valued at USD 57.91 billion in 2023, expected to reach USD 63.14 billion in 2024, and is projected to grow at a CAGR of 9.12%, to USD 106.71 billion by 2030.

Biophotonics is an interdisciplinary field that involves the application of light-based technologies to study biological materials. It encompasses the development and use of photonic devices and techniques to analyze, image, and manipulate living tissues at the molecular and cellular levels. The necessity of biophotonics arises from its capability to provide non-invasive, high-resolution, and precise diagnostic and therapeutic solutions, significantly advancing medical research, diagnostics, and treatment. The primary applications include imaging systems like optical coherence tomography, microscopy, and spectroscopy, which play crucial roles in early disease detection, personalized medicine, and minimally invasive treatments. Key end-use sectors are healthcare, pharmaceuticals, biotechnology, and environmental monitoring, with healthcare being the principal driver due to rising demands for advanced diagnostic procedures and treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 57.91 billion
Estimated Year [2024] USD 63.14 billion
Forecast Year [2030] USD 106.71 billion
CAGR (%) 9.12%

In terms of market growth, biophotonics is influenced by technological advancements, increasing government funding for research, and heightened awareness of early disease detection techniques. The rise in chronic diseases and the aging global population further fuel the demand for innovative diagnostic and therapeutic solutions. Potential opportunities lie in expanding applications for telemedicine and remote diagnostics, driven by recent global health crises emphasizing the need for contactless healthcare solutions. However, challenges such as high costs of equipment, complex regulatory requirements, and lack of skilled professionals pose significant roadblocks. Additionally, rapid technological evolution necessitates constant investment in R&D, which may strain resources for smaller players.

Innovation in biophotonics can be directed towards cost-effective, portable diagnostic tools, and integration with artificial intelligence for enhanced data analysis and predictive diagnostics. Businesses should also explore nanoscale imaging and minimally invasive optical biosensors as potential growth areas. Collaborations between academia and industry could expedite technological advancements. The biophotonics market presents a dynamic and rapidly growing landscape, characterized by intense R&D activities and evolving technological paradigms. Companies can maintain a competitive edge by investing in emerging technologies, fostering cross-disciplinary collaborations, and tailoring solutions to meet the specific needs of healthcare providers and patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biophotonics Market

The Biophotonics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in geriatric populations
    • Development of novel Photoacoustic Tomography (PAT) System
    • Adoption biophotonics in cell and tissue diagnostics
  • Market Restraints
    • Reluctance toward the adoption of new treatment practices
  • Market Opportunities
    • Use of biophotonics in non-medical sectors
    • Emergence of nanotechnology
  • Market Challenges
    • Lack of awareness of biophotonics technology

Porter's Five Forces: A Strategic Tool for Navigating the Biophotonics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biophotonics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biophotonics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biophotonics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biophotonics Market

A detailed market share analysis in the Biophotonics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biophotonics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biophotonics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biophotonics Market

A strategic analysis of the Biophotonics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biophotonics Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Carl Zeiss AG, Hamamatsu Photonics K.K., Idex Corporation, ImpediMed Limited, Lumenis Be Ltd., LUMICKS Technologies B.V., Magritek, Olympus Corporation, Oxford Instruments Group, PerkinElmer Inc., Photopharmics, Inc., Thermo Fisher Scientific Inc., THINKCYTE Inc., and VivoSight by Michelson Diagnostics Ltd..

Market Segmentation & Coverage

This research report categorizes the Biophotonics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Biosensors, Inside Imaging, Light Therapy, Microscopy, See-Through Imaging, Spectro Molecular, and Surface Imaging.
  • Based on End-Use, market is studied across Medical Diagnostics, Medical Therapeutics, Non-Medical Application, and Tests & Components.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in geriatric populations
      • 5.1.1.2. Development of novel Photoacoustic Tomography (PAT) System
      • 5.1.1.3. Adoption biophotonics in cell and tissue diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Reluctance toward the adoption of new treatment practices
    • 5.1.3. Opportunities
      • 5.1.3.1. Use of biophotonics in non-medical sectors
      • 5.1.3.2. Emergence of nanotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness of biophotonics technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Biophotonics Market, by Application

  • 6.1. Introduction
  • 6.2. Biosensors
  • 6.3. Inside Imaging
  • 6.4. Light Therapy
  • 6.5. Microscopy
  • 6.6. See-Through Imaging
  • 6.7. Spectro Molecular
  • 6.8. Surface Imaging

7. Biophotonics Market, by End-Use

  • 7.1. Introduction
  • 7.2. Medical Diagnostics
  • 7.3. Medical Therapeutics
  • 7.4. Non-Medical Application
  • 7.5. Tests & Components

8. Americas Biophotonics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Biophotonics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Biophotonics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Becton, Dickinson and Company
  • 2. Carl Zeiss AG
  • 3. Hamamatsu Photonics K.K.
  • 4. Idex Corporation
  • 5. ImpediMed Limited
  • 6. Lumenis Be Ltd.
  • 7. LUMICKS Technologies B.V.
  • 8. Magritek
  • 9. Olympus Corporation
  • 10. Oxford Instruments Group
  • 11. PerkinElmer Inc.
  • 12. Photopharmics, Inc.
  • 13. Thermo Fisher Scientific Inc.
  • 14. THINKCYTE Inc.
  • 15. VivoSight by Michelson Diagnostics Ltd.

LIST OF FIGURES

  • FIGURE 1. BIOPHOTONICS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHOTONICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHOTONICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHOTONICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHOTONICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHOTONICS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHOTONICS MARKET SIZE, BY BIOSENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHOTONICS MARKET SIZE, BY INSIDE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHOTONICS MARKET SIZE, BY LIGHT THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHOTONICS MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHOTONICS MARKET SIZE, BY SEE-THROUGH IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHOTONICS MARKET SIZE, BY SPECTRO MOLECULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHOTONICS MARKET SIZE, BY SURFACE IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHOTONICS MARKET SIZE, BY MEDICAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHOTONICS MARKET SIZE, BY NON-MEDICAL APPLICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHOTONICS MARKET SIZE, BY TESTS & COMPONENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOPHOTONICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA BIOPHOTONICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM BIOPHOTONICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. BIOPHOTONICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. BIOPHOTONICS MARKET, FPNV POSITIONING MATRIX, 2023